NCT05731284View on ClinicalTrials.gov

Platelet Rich Plasma as an Adjunct Therapy at the Time of Transvaginal Native Tissue Prolapse Surgery

NAActive, not recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 1, 2023

Primary Completion Date

July 30, 2026

Study Completion Date

December 31, 2028

Conditions
Pelvic Organ Prolapse
Interventions
PROCEDURE

Platelet rich plasma (PRP) Injection

Randomly picked (like the flip of a coin) by a computer to receive either platelet-rich plasma (PRP) or normal saline. This is a double-blind study. During vaginal prolapse surgery, the surgeon will inject PRP into the vaginal tissue at the surgical site.

PROCEDURE

Placebo

Normal saline Injection

Trial Locations (1)

35249

University of Alabama at Birmingham, Birmingham

All Listed Sponsors
lead

University of Alabama at Birmingham

OTHER